Showing results (101-110 of 288) with videos related to

Sort By:
Pageof 29
Blood|January 25, 2002
Acute promyelocytic leukemia: evolving therapeutic strategiesMartin S Tallman, Chadi Nabhan, James H Feusner, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2012
Rituximab-induced direct inhibition of T-cell activationDina Stroopinsky, Tamar Katz, Jacob M Rowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2023
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?Susan DeWolf, Martin S Tallman, Jacob M Rowe, et al.
European Journal of Immunology|July 28, 2009
Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacityDina Stroopinsky, Irit Avivi, Jacob M Rowe, et al.
Seminars in Hematology|September 6, 2002
Future clinical implications for farnesyltransferase inhibitors in hematologic malignanciesHagop M Kantarjian, Jorge E Cortes, Jacob M Rowe, et al.
Blood Reviews|September 6, 2021
Consolidation in AML: Abundant opinion and much unknownNir Weigert, Jacob M Rowe, Hillard M Lazarus, et al.
American Journal of Hematology|December 26, 2003
Stem cell transplantation post invasive fungal infection is a feasible taskIrit Avivi, Ilana Oren, Nuhad Haddad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2016
Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center ExperienceIrina Zaidman, Jacob M Rowe, Abdalla Khalil, et al.
Pageof 29